Figure 7. (A) Overall Survival curves of patients with 20q11.21 amplifications (altered group) and without 20q11.21 amplifications (unaltered group) in TCGA. Log-rank p=0.99. B. Overall Survival curves of patients with 20q11.21 amplifications (altered group) and without 20q11.21 amplifications (unaltered group) in the MSK-IMPACT cohort. Log-rank p=0.002.